Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Need money morning to post about it again
Honestly, in a float lock down scenario, the OTC would probably be the preferred exchange. I totally agree that the meme crowd is more intent on trading the NASDAQ symbols which is why LCTC continually gets passed over. We don't really want that crowd involved anyway unless it's at the tail end of the run when things are already frothy.
But if we could somehow lock up the float on the OTC and we get a series of good news, sky's the limit on this thing. I know we have been patiently waiting a long time, but hopefully its all worth it.
Prospects are good, small float is great. Only problem on the way to $20 is that it trades OTC. The meme crowd focuses on NASDAQ stocks probably since many brokerages now charge commission for OTC stocks.
According to market screener, yahoo finance, and seeking alpha, the insiders own 89.5% of the public float. That leaves 10.5% for the public investors, traders, etc. That’s about 255,000 shares available for the public to purchase.
I’ve been saying this for a long time, but if there ever was a time to take down the entire public float of a stock, I think it’s now/soon. Can you imagine if we start seeing some really good news roll in about multi-million dollar contracts, partnerships, etc. and there’s no stock available to buy?
I know I’m not selling my shares anytime soon. I don’t think you guys are selling your stock anytime soon. We just need to get the current available float into stronger hands and wait for the fireworks.
When it does start to run you either have to be happy with your position or be ready to pay up cause this can go from 2-20 very quickly
And at that time it will be go time.. :)
Not sure if you were on or listened to the annual shareholders meeting conference call but the CEO did mention that when the SpinDX technology is tested, reliable, and ready to go, they will start putting out headlines, news releases, and PR’s.
Basically giving us a heads up that things are heating up and they’re ready to start cooking. According to the quarterly report released last week, it still sounds like they are targeting years end.
Hopefully the “Wow Factor” appears in some of those news releases and we start seeing some volume and higher stock prices. With less than 200 total shareholders here, there’s plenty of room for growth.
I have been around for a while. Been watching this ticker for the right news.
As it’s sitting primed for a big runZ. Just waiting for they wow factor
Welcome to the board... I agree that there is not an overwhelming "wow" factor, but those of us that have followed this company for years, know that this company does not fluff and puff their news releases. They state the facts, and let investors interpret the value of the news.
There was a subtle difference in the way this news was reported by Lifeloc. This time, they released a press release that stated the highlights of their second quarter, which stated they had a quarterly profit, improved margins, validation testing has confirmed Spin Dx performance among human testing at the University of Colorado, they have added tests for cocaine and amphetamine, and have initiated work to detect fentanyl. They expect to begin Beta testing soon, with commercialization expected next year. Their R&D manager chimed in that the project is maintaining good momentum. There was a much different tone in this release. Couple this with recent insider buying... This is all pretty big news.
Is this going to send this stock soaring - probably not, but there is no reason to sell this stock if you are aware of this current news. This is still a great opportunity to accumulate stock in the bottom of it's it's long-term trading range, in my opinion.
It’s good stuff overall. It’s just missing that “wow” factor.
Highlights from the full Lifeloc Quarterly report:
Total assets are $2 Million higher than the current market cap:
Total Assets: $8,312,084
Progress and updates for the SpinDx:
We received the first prototype in 2018, advanced this device for robustness and manufacturability, and are now commercializing the device. We are optimistic about the results of the work to date and expect market introduction later in 2023 with partners for field demonstration. The SpinDx™ platform has the potential to improve real-time screening for a panel of high-abuse drugs, with the ability to efficiently measure relatively low concentrations of drugs such as cocaine, heroin, methamphetamine, fentanyl and other high-abuse drugs.
Firmware updates will be distributed through a subscription model. The disks and sample collection kits are the consumables used by the product to produce a significant recurring revenue stream. Development of broader drug panels, improved accuracy, and sampling methods according to market demands is ongoing. The first test we intend to offer is the SpinDx device with disks for delta-9-THC detection from an oral fluid sample collected from a test subject.
We anticipate that both quantitative and pass/fail disks will be made available, making this offering the only rapid quantitative test for delta-9-THC available on the market. Following this we expect to release a system based on our recently updated LX9 breathalyzer to collect a sample for analysis from breath, which, coupled with the SpinDx device, will complete our marijuana breathalyzer system. We have improved the detection sensitivity for delta-9-THC as well as the robustness of the device. We are continuing to work on developing this system into a device that can be used for roadside testing, as well as other venues requiring fast response. We have committed additional personnel and new equipment resources to this effort, with the goal of placing beta test units in 2023 with validation partners who have already been identified. We anticipate full commercialization to begin in 2024. Human trials have begun validating SpinDx detection of delta-9-THC at the detection limits of 10 ng/ml in real-world human samples. We intend to prioritize the acceleration of SpinDx even at the expense of short-term profitability, with research and development investments, including substantial validation testing, to be ongoing in 2023.
Our research and development expenses were $395,781 for the quarter ended June 30, 2023, representing an increase of 12% over the $352,910 in the same quarter a year ago. This increase is due in large part to our continuing emphasis on SpinDx and increased costs associated with its development.
This is the first time all year we have seen a close at $2.50. We desparetely need to see some volume come in and keep the buying interest high. We just got the full quarterly report out which I'll go through and see if I can highlight a couple things.
Strong end to the days trading... Dicamillo - you got your 2.50 close....
I'd also love to see this scenerio play out. If the SpinDx technology proves itself in the marketplace, this could be very beneficial for a big company to get involved and take it to the next level.
The opportunities are limitless if we actually see reliable and proven results from the SpinDx technology.
I would think a big company would throw 50m+ right now to buy them out. They got the breathalyzer business regardless and everything else can be a home run. There would be so many cost saving moves it would be more profitable currently.
50m would be $20 share.
Not so crazy.
LCTC has yet to close above $2.50 this year. This is a very important price level to break through if we want to see any type of upward momentum continue. We had a buyer in there on Friday and hopefully they are still around and want to pick up more shares.
Here’s some recent market cap comparisons. Keep in mind that SOBR and Cannabix continue to lose money every quarter and have never even been profitable.
LCTC = $4.8 million market cap
SOBR = $29.2 million market cap
BLOZF = $22.5 million market cap
I’ve always been of the opinion that Lifeloc should have a value equal to that of either of these companies. Obviously the market has not agreed so far.
Well said! There was some buying interest on Friday after the quarterly report was published.
There was some good stuff in the earnings report and it sounds like the team at Lifeloc is still content with having testing done this year and commercialization by next year.
I was impressed by this line:
“We continue with validation testing utilizing actual human samples obtained through the Colorado School of Public Health at the University of Colorado Anschutz, with results to date confirming SpinDx performance."
And I’m impressed they added fentanyl testing to the SpinDX drug panel. That’s going to prove beneficial in the near future as it continues to be distributed across the country.
The new rule of allowing saliva drug tests by the Department of transportation took effect on June 1, 2023. The DOT specifically mentioned THC and Cocaine in their ruling... “Allowing employers to use oral fluid testing may improve the effectiveness of drug testing,” DOT said. “Oral fluid testing can detect the recent use of some drugs, including marijuana and cocaine, while urine drug testing has a longer window of detection.”
Yes, the DOT finalized rule sets a 4 nanogram per milliliter screening test cutoff for THC, which it said in its earlier notice “would detect use of marijuana while eliminating possibilities of positive tests resulting from passive exposure.” I'm certain that Lifeloc is concentrating their efforts to improve the accuracy of their drug testing platform to meet the criteria set by the DOT.
A very important thing to remember here, is that prior to June 1, there was no set cutoff point for the amount of THC to be considered "over the limit." The DOT has now set this limit, which now creates a set point for testing, much like alcohol is set at .04 for commercial drivers, and .08 for most other drivers in most states. The argument that "there is no predetermined amount of THC in your system to be considered over the limit," is no longer valid. The DOT has set it at 4ng/ml.
For Lifeloc to achieve what they have in their R&D of this new product, without diluting shareholder value, and maintaining profitability, is an amazing feat in itself. Most small, OTC companies have no real revenue streams, and rely on their operations being completely funded by sale of their common stock. This is why there is such aversion from large fund investing in OTC companies. Lifeloc stands out of the crowd here, and, in my opinion, is being largely overlooked by investors. This is why buying now, when there is little to no interest in shares of LCTC stock, makes sense.
The management at Lifeloc seem to be confident in the product, and are starting to comment on the progress they are making - including current validation testing being performed on human samples. Still flying under the radar, but not for long....
As of the quarterly report from today we know that the Spin Dx technology is able to detect a limit of 10 ng/ml on real world human saliva tests.
I wonder how diffucult or easy it's going to be to get down to a 4 ng/ml dectection.
This is the very first time we have heard anything from Charles Gonzales, the Research and Development Manager.
We have to be excited about the addition of cocaine, amphetamines and fentanyl to the SpixDx drug panel. This is defintiely some good news.
And we finally have some validation testing being done with actual human samples at a college university. With result confirming SpinDx performance.
Progress is being made!
I'll take it. Let's see if we can get some upward momentum and some volume from this.
Quartely earnings are out. Lifeloc posted a profitable quarter: $.02/share.
More importantly we heard from Charles Gonzales, Research and Development Manager, who said,
"We have moved into the next critical phase of the SpinDx product development cycle, now developing our custom microfluidic disk with the first targeted drug being cannabis. We have also added tests for cocaine and amphetamines and have initiated work to detect fentanyl for our subsequent drug panel. The project is maintaining good momentum. We continue with validation testing utilizing actual human samples obtained through the Colorado School of Public Health at the University of Colorado Anschutz, with results to date confirming SpinDx performance."
Totally agree. If the timeline is to still have the SpinDX device ready to go by the end of this year (5 months away), insiders, management, employees should all be buying in the mid $1 range with a market cap at $4 million.
Step up to the plate and pick up some shares and let us know your just as confident as you were on the conference call.
Under $2 insiders should be buying.
At $1.70/share the market cap is right around $4 million. I also picked up some additional shares today. I know we have been saying the same thing for years but at some point in the near future this thing will get moving in the right direction.
Now people selling at 2.05. It’s July can this company start putting out news. Start buying shares in open market. Do something
Money is starting to flow...
https://www.chp.ca.gov/PressReleases/Pages/CHP-DISTRIBUTES-OVER-$19-MILLION-TO-FIGHT-IMPAIRED-DRIVING.aspx
It hit $34 in 2015
At most, there’s 100,000 Lifeloc shares from the float that aren’t locked up by us and other shareholders.
I would love to just take down the rest of the float (at these price levels it would take about $200,000) and just wait it out.
Could you imagine how easily this could just stair step higher once we get some good news and the float is entirely locked down by long term investors.
That’s the dream scenario.
Seems like bid has stabilized and someone eager to buy off ask.
There was also this article in reference to Best Stocks for Future Boom in THC Drug Testing:
https://moneyandmarkets.com/best-stocks-for-future-boom-thc-drug-testing/amp/
I believe your referring to the guys from money morning who published this article on Lifeloc a couple years ago.
https://moneymorning.com/2021/08/12/buy-this-4-micro-cap-stock-before-the-house-passes-the-infrastructure-bill/
Maybe we can send them a summary of the highlights from the recent annual shareholders meeting.
Someone bidding at 2.15. Let’s get some volume and start taking out the ask. Where is that financial website that put out some articles. Could use that now.
The beauty of this, is that Lifeloc has funded all of its R&D up to a near finished product, internally, through existing sales. It has not had to raise any capital, thus far. It has had a slight impact on earnings, but I feel they are taking the proper course for shareholders. Grant money is always good, but wouldn't count on it at this point.
Since they have already purchased a lot of the integral components for the marijuana breathalyzer last year, due to fear of supply disruptions, and the fact they will be expanding their in-house production facility this year, I think we have reason to start getting excited.
Thanks for the thorough response.
I wonder if there’s any chance we could possibly see another grant from the state of Colorado to give this thing a final push and provide some additional funding to see it through the finish line.
Hound labs has raised 10’s of millions in venture capital which I’m sure has helped them speed things up.
I would be nice to see some additional funding come from an external source.
Good morning...!
To answer your question - patience. There are only a handful of people that actually follow this stock. Now is the time to accumulate shares, before the buzz hits the Dow Jones Newswire later this year (hopefully). We all saw the stock move to ten dollars a share back in August of 2021, with very little volume, on nothing but news that US car makers may be required to install alcohol detection devices in cars in the future. Just think what will happen if Lifeloc actually makes a few press releases..?
My take from the shareholders call, is that they are still on track, just a little slower than anticipated - which is understanding, considering the scope of this project. Good sign that there is some insider buying, and that management seems upbeat going into the second half of this year.
Hound Labs is pre-selling their device, and my thoughts that when they actually release the units for sale, it will create a buzz, and possibly draw some attention to Lifeloc. A big advantage that Lifeloc has, is they have been in this space for decades. They know what is required for compliance of the breathalyzer units, they have a large, worldwide customer base - that will be easily converted to sales of the "Marijuana Breathalyzer." All of the other companies that are vying for a piece in this space, are new to this market, and most are privately held. Another advantage that Lifeloc has over their competitors, is the ability to possibly use Sandia Labs Spin Dx technology, to adapt their marijuana breathalyzers to detect a broad spectrum of illicit drugs - including Heroin, Cocaine, and Phentanyl. None of the other companies can come close.
I still maintain my original position in this company from years ago. I held through the $10 spike a couple of years ago, and have since accumulated more shares over this past winter. Yes, anything under $2 was a gift, and still probably a gift at anything under $4. Just my opinion of course. We'll see...
Greetings Enery Manager. Haven't heard from you since the shareholder's call.
Any thoughts/opinions on if you think the team at Lifeloc actually has what it takes to get this thing done soon?
If they pull it off, we both know the currrent price is a gift. If we are being given the run around yet again and we get nothing by year end, we probably sit in this $1-$4 range with minimal volume.
Either outcome, I think I'm going to make it a point to go to next year's annual shareholders meeting. Either to personally congratulate them or give them some hell.
According to the Hound Labs website,
"The HOUND® CANNABIS BREATHALYZER will begin shipping in spring 2023. Connect with our team to place your order and secure your shipping window."
We will keep you updated on product availability. The HOUND® CANNABIS BREATHALYZER will initially ship in limited quantities in the coming months.
There is also a wait list for early access. "Joining the Wait List will help to ensure that your organization has the opportunity to reserve a HOUND® MARIJUANA BREATHALYZER before general availability."
It would be great to find out what they are selling the initial units for and how many units are on the wait list.
First to market is definitely a big win but it seems like there will be plenty to go around due to high demand for this thing.
Another small piece of good news to share was when I asked the CEO if the SpinDX technology was able to test for fentanyl, I received the following response:
"Currently, we do not have a detection assay for fentanyl, but this is on the short list of drugs to add given the high attention that that drug has today. I have complete confidence that that will not be difficult to add to the panel."
I think it's of utmost importance to have access to a machine that can quickly and accuratley test for fentanly and it sounds like it's in the works and is being made a priority to get added.
After reviewing the slide show presentation and going over the notes from today's call, the one thing I am most excited about is the current stock price of LCTC. This is absolutley not a company that is worth just $4-$5 million. Keep in mind that Cannabix currently has a market cap of $36.5 million and does anyone here think that Cannabix has more going for it than Lifeloc?
We also now know when it's go time. They told us outright that when the tech is ready, we will start seeing the news flow increase.
We are not there yet, but we are close.
I have to imagine the big boys start to get interested if/when Lifeloc proves the technology behind the Spin DX is shown to work and be reliable.
When the news releases start rolling in with human trials and validation, that’s when the overall interest should really start.
Continuing to collect shares under $2.00 is a gift as long as what they said on this call comes to fruition.
If the technology proves itself and competition is minimal, a market cap of $20-$50 million should be reachable and buy out/merger interest from the big boys is certainly a possible outcome.
I totally agree that there was excitement in his voice and the way he talked about the near future.
One of our biggest takeaways is the fact that the news will flow when the time is right and they are ready. As soon as we see that first PR/news release relating to the Spin DX technology that is my sign that it’s go time. I don’t expect this in the coming months but he sounded pretty confident to be ready to go by years end.
Needed the additional 5,000 sq feet space is a good sign.
Seeing an actual picture of the SpinDX device on the presentation slide is a good sign.
Human user samples being collected is a good sign.
Demonstrating TCH levels down to 10ng/ml with real world testing is a good sign.
DOT guidance changes which make the Spin DX technology more attractive is a good sign.
I was impressed with this call.
Keep the focus and get it done!
I felt like that was the most excited I have heard him. He seems to have a plan with press releases and brokers with that list he mentioned.
I was on and asked about competition. I just hope they're not too far behind Draeger and a couple of other small companies. It was encouraging to hear that they're taking additional space in their building to get this done.
I was on the call and submitted some questions which I thought Wayne did a fair job answering.
It sounds like the excitement comes when they approach the finish line and get the job done.
It does seem like they have prioritized commercialization of the SpinDX and have commenced human trials which is very good. They are confident the technology works but underestimated the complexity.
When the news starts flowing, that’s when the magic happens.
Overall I thought it was a promising call that has a lot to look forward to but don’t expect too much in the near future. When they are ready, it sounds like they will let us know.
Wayne did a good job on this call today. I’ll give credit when credit is due. There is reason to be excited as a shareholder.
Followers
|
20
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1754
|
Created
|
02/23/14
|
Type
|
Free
|
Moderators |
Lifeloc (OTC:LCTC) is a public company established in 1983. We introduced our first breathalyzer to the US Department of Transportation in 1988. We are an American manufacturer of professional-grade, platinum fuel cell based instruments for alcohol detection, measurement and enforcement.
Since our founding, our corporate mission has been to build the most precise, reliable and easiest to use breath alcohol testing devices in the industry. We take pride in offering everything an organization requires to establish an effective alcohol monitoring program including equipment, mouthpieces, factory authorized training and certifications, and a complete line of alcohol testing supplies and calibration equipment.
-Today, our highly accurate and reliable fuel cell devices are the preferred choice by professionals in countries around the world. We back everything we sell with exemplary customer service and technical support.Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |